Novartis to limit M&A spend to 5% of market value | Financial Times
Speakers · Total Health · Chicago, October 19-20, 2022
Narasimhan's Culture Club On Song At Novartis :: In Vivo
Speakers · Total Health · Chicago, October 19-20, 2022
Amazon.com: Rajay Bagaria: Books, Biography, Blog, Audiobooks, Kindle
Digital transformation in the life sciences supply chain – show me the data | Kinaxis
Novartis to acquire US-based cancer drugmaker Endocyte for $2.1 billion | Business Standard News
Novartis CEO Cautions on Efficacy of Trump-Touted Covid-19 Treatment - TheStreet
Novartis agrees $9.7bn deal for US cholesterol drugmaker | Financial Times
Amazon.com: Victor Harrington: Books, Biography, Blog, Audiobooks, Kindle
Novartis's new chief sets sights on 'productivity revolution' | Financial Times
CNBC Halftime Report on Twitter: "Today on Halftime, don't miss @MegTirrell's #CNBCExclusive interview with Novartis CEO @VasNarasimhan! #JPM21 https://t.co/kmvOe2V4WJ" / Twitter
News: Indian-origin Vasant Narasimhan appointed as the new CEO of Novartis — People Matters
Ousted Novartis scientist denies wrongdoing in data manipulation scandal - Super News
The CEO of Swiss pharma giant Novartis voluntarily gave up $400,000 of his bonus, thanks to a controversy swirling around the world's most expensive drug | Business Insider India
China Lost, Jeff Bezos Goes Big on India: Foreign Media | Technology News
Amazon could partner with a PBM to blaze its trail into pharma: analysts | Fierce Pharma
There's an explosion of data & digital opportunities in Indian healthcare: Vasant Narasimhan, CEO, Novartis - The Economic Times
Novartis says all options open on Sandoz after private equity interest emerges - Jnews
Johnson & Johnson chief figures Amazon could shake up pharma's distribution, rebates and more | Fierce Pharma
A Year In, Novartis' Boss Faces The World
Novartis CEO Vas Narasimhan on M&a and Taking Earlier Risks on New Technology
Committed to growing over 4% through 2026, says Novartis CEO
